Grants for Public and State controlled institutions of higher education - Food and Nutrition

This funding opportunity provides financial support for agricultural development projects in developing countries and emerging democracies, focusing on increasing productivity and trade through the monetization of U.S. agricultural commodities.

This funding opportunity is designed to support clinical centers conducting research on the development of Type 1 diabetes following episodes of acute pancreatitis, focusing on understanding its causes, progression, and risk factors in a diverse population.

This funding opportunity provides financial support to organizations that will help improve diabetes prevention and management for underserved populations by offering expertise, training, and resources to enhance health equity.

This grant provides funding for innovative, interdisciplinary research projects that aim to advance understanding and treatment of diseases related to diabetes, digestive disorders, liver diseases, metabolic and nutritional disorders, kidney and urologic diseases, and obesity.

This funding opportunity provides financial support to state and local governments, educational institutions, nonprofits, and other organizations to implement strategies that promote better nutrition and physical activity, ultimately reducing chronic disease risks in their communities.

This funding opportunity supports U.S. institutions in developing educational programs that provide undergraduate and early-stage graduate students with hands-on research experiences in kidney technology development and entrepreneurship.

The Minnesota Department of Health (MDH) is offering the International Medical Graduate Career Guidance and Support Program to address barriers faced by international medical graduates (IMGs) in becoming licensed and practicing medicine in Minnesota. This initiative aligns with the broader mission of strengthening the state's healthcare workforce, expanding access to care, fostering healthy communities, and providing culturally responsive care to underserved populations. The program aims to integrate the potential of IMGs into Minnesota's health system, recognizing their significant contributions. The primary beneficiaries of this grant program are immigrant international medical graduates who are seeking to enter the Minnesota health workforce. The program's impact goals are centered on supporting these IMGs through career guidance and support services, ultimately facilitating their licensure and practice in the state. By doing so, the program contributes to a more diverse and robust healthcare workforce capable of meeting the diverse needs of Minnesota's communities. The program's priorities and focuses include awarding grants to eligible nonprofit organizations and postsecondary educational institutions. These organizations must be located in Minnesota, be in good financial standing, and demonstrate strong experience in working with immigrants and refugees, working with IMGs, and providing health care career guidance and support. This ensures that the awarded funds are channeled through organizations with proven capabilities in supporting the target population. Expected outcomes include an increase in the number of IMGs successfully integrated into the Minnesota health workforce. Measurable results will be tied to the number of awards distributed (estimated one or two awards) and the range of funding provided ($100,000 to $400,000 per award, with an estimated total of $400,000-$500,000 available). While specific quantitative metrics for IMG licensure are not explicitly detailed, the success of the program will be evident in the enhanced support and guidance offered to IMGs, leading to their increased participation in the state's healthcare system. The program's strategic priority is to address a critical workforce gap and promote equitable access to healthcare for all Minnesotans.

This funding opportunity is designed to support researchers investigating the connections between HIV/AIDS and various health issues related to diabetes, digestive, kidney, and metabolic diseases, particularly focusing on the complications and social factors affecting people living with HIV.

Not available

This grant provides funding to organizations that promote vaccine confidence and health equity through partnerships and educational outreach, particularly targeting underserved populations across the United States.

The main objective of this NOFO is to foster development and testing of technologies adaptable to aging-related changes in older adults (aged 65 years or older) with T1D to improve diabetes management and quality of life. Older adults may have increased vulnerability to hypoglycemia, cognitive impairment and/or multiple co-morbidities which may affect the risks and benefits of these technologies in this population. Projects will be funded to a) develop and test new technologies and b) to adapt and test existing technologies. It is expected that aging-adaptive diabetes technologies that address barriers for use among older adults with T1D will improve usability, adoption and adherence decreasing the risk of hypoglycemia (and hypoglycemia unawareness) while enhancing glycemic control, facilitating better diabetes management, and improving quality of life for these individuals and their caregivers.

This funding opportunity supports independent research projects in health-related fields for a wide range of eligible applicants, including universities, nonprofits, and small businesses, without allowing clinical trials.

The Georgia Council for the Arts (GCA) is offering the 2024 Vibrant Communities Grants, a program designed to support single art projects across various counties in Georgia. This initiative aligns with the GCA's mission to increase the reach of arts grants statewide, as mandated by the Georgia Legislature. The program aims to fund diverse arts programs in as many counties as possible, thereby fostering vibrant cultural landscapes and promoting artistic engagement within communities. The grants are intended to enhance local arts scenes and provide opportunities for artistic expression and appreciation. The target beneficiaries of the Vibrant Communities Grants are non-profit organizations with 501(c)3 status, local government entities, public libraries, and schools, colleges, or universities located within specific eligible Georgia counties. The impact goals are to support and expand arts programs, ensuring broad access to cultural activities. This includes enabling various artistic endeavors such as performances, art exhibits, educational workshops, and artist residencies. By funding these projects, GCA seeks to enrich communities, provide creative outlets, and promote the arts as a vital component of local development. The program prioritizes a wide array of arts projects, including theatre productions, concerts, class field trips, art exhibits, murals, art festivals, and art classes. Notably, due to the ongoing impact of COVID, online programs are also eligible for funding. The focus is on projects that can be completed between October 15, 2024, and June 1, 2025, and must take place within the applicant's county. A key requirement is a 50% cash match for the grant request amount, emphasizing community investment and shared responsibility. Projects promoting specific religious doctrines or political parties are not eligible. Expected outcomes include a broader distribution of arts funding across Georgia, leading to an increase in local arts programming and engagement. Measurable results would be the number of funded projects, the types of artistic disciplines supported, and the geographical spread of these initiatives across the eligible counties. The grants are expected to range from $1,000 to $5,000 per project, ensuring that a greater number of smaller-scale, impactful projects can be realized. This strategic approach reflects the GCA's theory of change, which posits that by decentralizing arts funding and making it accessible to a wider range of organizations and counties, they can cultivate more vibrant, culturally rich communities throughout the state.

This funding opportunity supports institutions in creating collaborative training networks for early-career researchers focused on advancing studies in kidney, urologic, and hematologic diseases.

This funding opportunity provides substantial financial support to higher education institutions and nonprofit organizations to establish collaborative centers that advance research and resources for HIV/AIDS.

This grant provides funding to support small farmers and public entities in Maryland to aggregate local food products for sale to wholesale and institutional markets, enhancing the local food system.

This funding opportunity provides financial support to schools and school districts to conduct a pilot study aimed at reducing harmful contaminants in meals served to students and improving their nutritional quality.

The National Institutes of Health (NIH) hereby notify recipient organizations holding specific types of NIH grants, listed in the full Funding Opportunity Announcement (FOA), that applications for change of recipient organization may be submitted to this FOA. This assumes such a change is programmatically permitted for the particular grant. Applications for change of recipient organization are considered prior approval requests (as described in Section 8.1.2.7 of the NIH Grants Policy Statement) and will be routed for consideration directly to the Grants Management Specialist named in the current award. Although requests for change of recipient organization may be submitted through this FOA, there is no guarantee that an award will be transferred to the new organization. All applicants are encouraged to discuss potential requests with the awarding IC before submission.

Modified release (MR) oral drug products are considered to have a high risk for alcohol dose dumping (ADD) because they contain large quantities of drug(s), designed to release over a prolonged period of time. Accidental exposure of these products to alcohol can result in the relatively rapid release of large quantities of drug with severe side effects, including death. To mitigate this risk, the FDA recommends conducting an in vitro alcohol dose dumping assessment in 0%, 5%, 20%, and 40% alcoholic dissolution media for all prospective generic versions of MR oral drug products. To date, ADD assessments have not been harmonized globally. For instance, the U.S. FDA recommends testing up to 40% alcoholic media while the European Medicines Agency recommends testing up to 20% alcoholic media. This type of difference can present a challenge for formulators designing products for multiple markets, as historical data has shown release from MR oral products do not always follow a linear response (either increasing or decreasing) to increasing alcohol concentrations. In addition, interpretation of an ADD assessment may be limited by the inability of the test to predict in vivo behavior. The purpose of this research is to develop tools that 1) facilitate the development of MR generic drug products that have a low potential for ADD, 2) support regulatory decision making during the assessment of such products, and 3) provide evidence that enables FDA to develop more specific recommendations for efficiently demonstrating a low or comparative potential of alcohol dose dumping for MR oral drug products containing high risk drugs.

This funding opportunity supports researchers in discovering and validating new targets for developing safe and effective pain treatments with minimal side effects and low addiction risk.